Meconium Ileus
- PMID: 30725693
 - Bookshelf ID: NBK537008
 
Meconium Ileus
Excerpt
In neonates, meconium Ileus (MI) is one of the earliest manifestations in patients with cystic fibrosis (CF). It presents in up to 20% of patients with CF. The inspissated meconium obstructs the small intestine at the level of the terminal ileum. If left untreated, the prognosis is poor.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
 
 
 
Sections
References
- 
    
- Sathe M, Houwen R. Meconium ileus in Cystic Fibrosis. J Cyst Fibros. 2017 Nov;16 Suppl 2:S32-S39. - PubMed
 
 - 
    
- Gorter RR, Karimi A, Sleeboom C, Kneepkens CM, Heij HA. Clinical and genetic characteristics of meconium ileus in newborns with and without cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010 May;50(5):569-72. - PubMed
 
 - 
    
- Dupuis A, Keenan K, Ooi CY, Dorfman R, Sontag MK, Naehrlich L, Castellani C, Strug LJ, Rommens JM, Gonska T. Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Genet Med. 2016 Apr;18(4):333-40. - PubMed
 
 - 
    
- ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Obstet Gynecol. 2011 Apr;117(4):1028-1031. - PubMed
 
 
Publication types
LinkOut - more resources
Full Text Sources